NCT02839876View on ClinicalTrials.gov

Intravenous Versus Oral Acetaminophen in Primary Total Hip Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

March 14, 2017

Primary Completion Date

October 2, 2018

Study Completion Date

October 31, 2018

Conditions
OsteoarthritisAcetaminophenArthroplasty, Hip Replacement
Interventions
DRUG

Intravenous acetaminophen

Subject receives 1 g acetaminophen by the intravenous route every 6 hours for 4 doses beginning in the preoperative holding area.

DRUG

Oral acetaminophen

Subject receives 1 g acetaminophen by the oral route every 6 hours for 4 doses beginning in the preoperative holding area.

Trial Locations (1)

27710

Duke University Hospital, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER

NCT02839876 - Intravenous Versus Oral Acetaminophen in Primary Total Hip Arthroplasty | Biotech Hunter | Biotech Hunter